Beyond Batten Disease Foundation gibt Vereinbarung mit Actelion Pharmaceuticals Ltd bekannt, um Arzneimittel für BBDF-101 zu entwickeln ...Middle East

AUSTIN, Texas, 3. März 2021 /PRNewswire/ - Die Beyond Batten Disease Foundation (BBDF) freut sich, eine Vereinbarung mit Actelion Pharmaceuticals Ltd, einem Unternehmen der Janssen Pharmaceutical Company of Johnson & Johnson, über die Bereitstellung von Zavesca® (Miglustat) für die...

Hence then, the article about beyond batten disease foundation gibt vereinbarung mit actelion pharmaceuticals ltd bekannt um arzneimittel fur bbdf 101 zu entwickeln was published today ( Wednesday 03/03/2021 - 09:15 PM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Beyond Batten Disease Foundation gibt Vereinbarung mit Actelion Pharmaceuticals Ltd bekannt, um Arzneimittel für BBDF-101 zu entwickeln )

Also on site :

• Blackpink’s Jisoo to Receive Madame Figaro Rising Star Award at Canneseries
• Family sues ChatGPT-maker OpenAI over school shooting in Canada
• Walmart's 'Beautiful' Midcentury Modern TV Stand 'Looks More Expensive Than It Is,' and It's Now Only $62